E
Enanta Pharmaceuticals, Inc. (ENTA)
NMS – Real Time Price. Currency in USD
14.53
-0.93 (-6.02%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
14.53
-0.93 (-6.02%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.44 | 6.05 | 10 | |
| Quick ratio | 4.44 | 5.63 | 10 | |
| Debt to Equity | 1.53 | 0.30 | 4.0 | |
| Debt to Assets | 0.59 | 1.04 | 4.0 | |
| Interest coverage | -3.65 | -16.91 | 1.0 | |
| Weighted average score | 5.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 86M | 79M | 68M | 65M | 67M |
| Gross Profit | 83M | 77M | 65M | 61M | 62M |
| Operating Income | -124M | -137M | -122M | -85M | -73M |
| Net Income | -122M | -134M | -116M | -82M | -72M |
| EBITDA | -121M | -135M | -119M | -81M | -68M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 14.08 | 54.02 | 9.0 |
| Next quarter | -5.49 | 43.96 | 5.5 |
| Current year | 3.8 | 39.1 | 7.0 |
| Next year | -3.18 | 18.99 | 5.0 |
| Weighted average score | 6.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 23.07 | 36.16 | 51.72 | -49 | 7.8 |
| Y/Y | 9.76 | 46.44 | 60 | 53.64 | 9.0 |
| 3y average | -8.68 | 10.94 | 12.03 | 17.15 | 6.0 |
| 5y average | -11.6 | -27.93 | -26.23 | -265 | 1.0 |
| Weighted average score | 6.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $193.2M significantly exceeds cash reserves ($37.4M), raising financial stability concerns
Total current assets $198.7M exceed Total current liabilities $44.7M, highlighting excellent liquidity
Debt-to-equity ratio (1.5) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-3.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$11.8M limits the company's ability to reinvest or pay down debt